Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Retained Earnings: 2018-2020

Historic Retained Earnings for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to -$118.2 million.

  • Black Diamond Therapeutics' Retained Earnings fell 127.99% to -$218.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$218.0 million, marking a year-over-year decrease of 127.99%. This contributed to the annual value of -$118.2 million for FY2020, which is 131.95% down from last year.
  • As of FY2020, Black Diamond Therapeutics' Retained Earnings stood at -$118.2 million, which was down 131.95% from -$51.0 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Retained Earnings ranged from a high of -$15.7 million in FY2018 and a low of -$118.2 million during FY2020.
  • Over the past 3 years, Black Diamond Therapeutics' median Retained Earnings value was -$51.0 million (recorded in 2019), while the average stood at -$61.6 million.
  • Data for Black Diamond Therapeutics' Retained Earnings shows a maximum YoY slumped of 224.40% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Black Diamond Therapeutics' Retained Earnings stood at -$15.7 million in 2018, then plummeted by 224.40% to -$51.0 million in 2019, then plummeted by 131.95% to -$118.2 million in 2020.